MedPath

ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair

Not Applicable
Recruiting
Conditions
Ventral Hernia
Abdominal Wall Defect
Registration Number
NCT06367309
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

This study investigates on the effect of two different operative techniques to treat abdominal wall hernias.

The goal of this clinical trial is to learn if the eTEP (Extended totally extraperitoneal repair) technique leads to a better outcome than the IPOM (Intraperitoneal onlay mesh) technique.

The main questions it aims to answer are:

* pain after the operation

* rate of complications

* rate of recurrence and reoperations

* quality of life.

Participants will:

Either be operated using the eTEP or the IPOM technique. Be followed up either in person or via email / phone call at day 1, day 7, day 14, 6 weeks, 6 months, 1, 3 and 5 years after the surgery to asses the above-stated main and some more outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
138
Inclusion Criteria
  • Patient age >18 years
  • Informed consent obtained
  • Primary or incisional ventral hernia
  • Epigastric, umbilical or infraumbilical ventral hernias with transversal diameter >1cm and </= 4cm, +/- rectus diastasis which doesn't demand specific treatment
  • If multiple hernias: cumulative transversal diameter </= 4cm
  • Considered eligible for minimally-invasive approach
Exclusion Criteria
  • Subxyphoidal or suprapubic hernias
  • precedent hernia treatment with mesh placement in the retromuscular space
  • liver disease defined by the presence of ascites
  • end-stage renal disease requiring dialysis
  • need of an emergency surgery
  • pregnancy
  • need of rectus diastasis treatment intraoperatively

Criteria for participating surgeons

  • Each participating surgeon has performed 20 or more laparoscopic IPOM procedures and 20 or more eTEP procedures.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pain outcome using the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form 3a24 hours

pain, measured using the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form 3a 24 hours after the surgical procedure

primary outcome: pain numeric rating scale (NRS)24 hours

pain, measured on the numeric rating scale (NRS) 0 - 10 24 hours after the surgical procedure.

Secondary Outcome Measures
NameTimeMethod
pain mid-term12 months

pain, measured on the visual analog scale (NRS) 0 - 10 and using the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form 3a after 7days, 14 days, 6 weeks, 6 and 12 months (NRS 0-10)

Functional recovery5 years

Functional recovery measured using the European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L) Questionnaire at 7 and 14 days, 6 weeks, 6 months, 1, 3 and 5 years.

The questionnaire uses 5 questions describing the patients health \& abilities on that particular day and a visual analogue scale question (0 = worst, 100 = best) on the patients health on that particular day.

LOS30 days

Length of hospital stay

Adverse events30 days

Intraoperative adverse events (Bleeding, conversion rate, injury to bowel structures) Postoperative adverse events (ileus, seroma, hematoma, Surgical site infections (SSI), pulmonary embolism) according to Clavien-Dindo Classification and scored according to the Comprehensive Complication Index (CCI) up to 30 days after surgery.

recurrence and reoperation5 years

Long-term outcome at 3 and 5 years with assessment of the number of patients with clinical and / or radiological recurrences and with assessment of the number of patients who needed reoperations for either recurrences or other reasons such as mechanical bowel obstructions

Quality of life (SF 12)5 years

Quality of life using the short form-12 (SF-12) questionnaire at 7 and 14 days, 6 weeks, 6 months, 1, 3 and 5 years.

The 12-item Short Form Survey (SF-12) is a general health questionnaire that was first published in 1995 as part of the Medical Outcomes Study (MOS). The SF-12 was constructed using questions drawn from each of the 8 dimensions of the MOS 36 item Short Form Survey (SF-36).

Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12).

The score ranges from 0 - 100, with a higher score indicating better physical and mental health functioning.

Trial Locations

Locations (1)

St. Clara Hospital

🇨🇭

Basel, Basel-Stadt, Switzerland

St. Clara Hospital
🇨🇭Basel, Basel-Stadt, Switzerland
Fiorenzo Angehrn, MD
Contact
fiorenzo.angehrn@clarunis.ch

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.